Intracellular lipid droplet accumulation occurs early following viral infection and is required for an efficient interferon response

Abstract

Lipid droplets (LDs) are increasingly recognized as critical organelles in signalling events, transient protein sequestration and inter-organelle interactions. However, the role LDs play in antiviral innate immune pathways remains unknown. Here we demonstrate that induction of LDs occurs as early as 2 h post-viral infection, is transient and returns to basal levels by 72 h. This phenomenon occurs following viral infections, both in vitro and in vivo. Virally driven in vitro LD induction is type-I interferon (IFN) independent, and dependent on Epidermal Growth Factor Receptor (EGFR) engagement, offering an alternate mechanism of LD induction in comparison to our traditional understanding of their biogenesis. Additionally, LD induction corresponds with enhanced cellular type-I and -III IFN production in infected cells, with enhanced LD accumulation decreasing viral replication of both Herpes Simplex virus 1 (HSV-1) and Zika virus (ZIKV). Here, we demonstrate, that LDs play vital roles in facilitating the magnitude of the early antiviral immune response specifically through the enhanced modulation of IFN following viral infection, and control of viral replication. By identifying LDs as a critical signalling organelle, this data represents a paradigm shift in our understanding of the molecular mechanisms which coordinate an effective antiviral response.

References 64

1. 1.

   Arrese EL, Saudale FZ, Soulages JL. Lipid droplets as signaling platforms linking metabolic and cellular functions. Lipid Insights. 2014;7:7-16.

   Not in our library10.4137/lpi.s11128

2. 2.

   den Brok MH, Raaijmakers TK, Collado-Camps E, Adema GJ. Lipid droplets as immune modulators in myeloid cells. Trends Immunol. 2018;39:380-392.

   Not in our library10.1016/j.it.2018.01.012

3. 3.
   The lipid droplet—a well-connected organelle · 2015

   No notice
4. 4.

   Henne, W. M., Reese, M. L. & Goodman, J. M. The assembly of lipid droplets and their roles in challenged cells. EMBO J. 38, e98947 (2019).

   Not in our library10.15252/embj.2019101816

5. 5.

   Mattos KA, et al. Modulation of lipid droplets by Mycobacterium leprae in Schwann cells: a putative mechanism for host lipid acquisition and bacterial survival in phagosomes. Cell. Microbiol. 2011;13:259-273.

   Not in our library10.1111/j.1462-5822.2010.01533.x

6. 6.

   Rank RG, Whittimore J, Bowlin AK, Wyrick PB. In vivo ultrastructural analysis of the intimate relationship between polymorphonuclear leukocytes and the chlamydial developmental cycle. Infect. Immun. 2011;79:3291-3301.

   Not in our library10.1128/iai.00200-11

7. 7.

   Nicolaou G, Goodall AH, Erridge C. Diverse bacteria promote macrophage foam cell formation via Toll-like receptor-dependent lipid body biosynthesis. J. Atheroscler. Thromb. 2012;19:137-148.

   Not in our library10.5551/jat.10249

8. 8.

   D’Avila H, et al. Host cell lipid bodies triggered by trypanosoma cruzi infection and enhanced by the uptake of apoptotic cells are associated with prostaglandin E2 generation and increased parasite growth. J. Infect. Dis. 2011;204:951-961.

   Not in our library10.1093/infdis/jir432

9. 9.

   Tanigawa K, et al. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae. FEMS Microbiol. Lett. 2008;289:72-79.

   Not in our library10.1111/j.1574-6968.2008.01369.x

10. 10.

    Pacheco P, et al. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism. J. Immunol. 2002;169:6498-6506.

    Not in our library10.4049/jimmunol.169.11.6498

11. 11.

    Dutta, A., Banerjee, S. & Sinha, D. K. Lipid Droplet metabolism dependent microbial defense in pre-immune zebrafish embryos. bioRxiv 478859 (2018). 10.1101/478859.

    Not in our library

12. 12.

    Anand P, et al. A novel role for lipid droplets in the organismal antibacterial response. Elife. 2012;1:e00003.

    Not in our library10.7554/elife.00003

13. 13.
    Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-γ/HIF-1α signaling and supports host defense · 2018

    No notice
14. 14.

    Truong N, Love-Rutledge S, Lydic T, Olson LK. Effect of interferon gamma on neutral lipid levels, lipid droplet formation, and antiviral responses in pancreatic islets and INS-1 β cells. FASEB J. 2019;33:654.11-654.11.

    Not in our library

15. 15.

    Barletta ABF, et al. Emerging role of lipid droplets in Aedes aegypti immune response against bacteria and Dengue virus. Sci. Rep. 2016;6:19928.

    Not in our library10.1038/srep19928

16. 16.

    Weed, D. J. & Nicola, A. V. Herpes simplex virus Membrane Fusion. Cell Biology of Herpes Viruses 29–47 (2017) 10.1007/978-3-319-53168-7_2.

    Not in our library10.1007/978-3-319-53168-7_2

17. 17.

    Cohen FS. How Viruses Invade Cells. Biophys. J. 2016;110:1028-1032.

    Not in our library10.1016/j.bpj.2016.02.006

18. 18.

    Pol A, Gross SP, Parton RG. Review: biogenesis of the multifunctional lipid droplet: lipids, proteins, and sites. J. Cell Biol. 2014;204:635-646.

    Not in our library10.1083/jcb.201311051

19. 19.
    Fast type I interferon response protects astrocytes from flavivirus infection and virus-induced cytopathic effects · 2016

    No notice
20. 20.
    Lipid droplet density alters the early innate immune response to viral infection. · 2018

    Not checked
21. 21.

    Rohwedder A, Zhang Q, Rudge SA, Wakelam MJO. Lipid droplet formation in response to oleic acid in Huh-7 cells is mediated by the fatty acid receptor FFAR4. J. Cell Sci. 2014;127:3104-3115.

    Not in our library10.1242/jcs.145854

22. 22.

    Fujimoto Y, et al. Involvement of ACSL in local synthesis of neutral lipids in cytoplasmic lipid droplets in human hepatocyte HuH7. J. Lipid Res. 2007;48:1280-1292.

    Not in our library10.1194/jlr.m700050-jlr200

23. 23.

    Roers A, Hiller B, Hornung V. Recognition of Endogenous Nucleic Acids by the Innate Immune System. Immunity. 2016;44:739-754.

    Not in our library10.1016/j.immuni.2016.04.002

24. 24.

    Desmyter J, Melnick JL, Rawls WE. Defectiveness of interferon production and of rubella virus interference in a line of African green monkey kidney cells (Vero). J. Virol. 1968;2:955-961.

    Not in our library10.1128/jvi.2.10.955-961.1968

25. 25.

    Mosca JD, Pitha PM. Transcriptional and posttranscriptional regulation of exogenous human beta interferon gene in simian cells defective in interferon synthesis. Mol. Cell. Biol. 1986;6:2279-2283.

    Not in our library10.1128/mcb.6.6.2279-2283.1986

26. 26.

    Gubern A, et al. Group IVA phospholipase A2 is necessary for the biogenesis of lipid droplets. J. Biol. Chem. 2008;283:27369-27382.

    Not in our library10.1074/jbc.m800696200

27. 27.

    Penrose H, et al. Epidermal growth factor receptor mediated proliferation depends on increased lipid droplet density regulated via a negative regulatory loop with FOXO3/Sirtuin6. Biochem. Biophys. Res. Commun. 2016;469:370-376.

    Not in our library10.1016/j.bbrc.2015.11.119

28. 28.

    Johns TG, et al. Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. Proc. Natl Acad. Sci. USA. 2003;100:15871-15876.

    Not in our library10.1073/pnas.2036503100

29. 29.

    Miller DL, et al. Emergence of MCF-7 cells overexpressing a transfected epidermal growth factor receptor (EGFR) under estrogen-depleted conditions: evidence for a role of EGFR in breast cancer growth and progression. Cell Growth Differ. 1994;5:1263-1274.

    Not in our library

30. 30.

    De Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc. Natl Acad. Sci. 1978;75:4001-4005.

    Not in our library10.1073/pnas.75.8.4001

31. 31.

    Zhang J, et al. Flaviviruses exploit the lipid droplet protein AUP1 to trigger lipophagy and drive virus production. Cell Host Microbe. 2018;23:819-831.e5.

    Not in our library10.1016/j.chom.2018.05.005

32. 32.

    Leier HC, Messer WB, Tafesse FG. Lipids and pathogenic flaviviruses: an intimate union. PLoS Pathog. 2018;14:e1006952.

    Not in our library10.1371/journal.ppat.1006952

33. 33.

    Zhang J, Lan Y, Sanyal S. Modulation of lipid droplet metabolism-A potential target for therapeutic intervention in flaviviridae infections. Front. Microbiol. 2017;8:2286.

    Not in our library10.3389/fmicb.2017.02286

34. 34.

    Laufman O, Perrino J, Andino R. Viral generated inter-organelle contacts redirect lipid flux for genome replication. Cell. 2019;178:275-289.e16.

    Not in our library10.1016/j.cell.2019.05.030

35. 35.

    Thiam AR, Beller M. The why, when and how of lipid droplet diversity. J. Cell Sci. 2017;130:315-324.

    Not in our library10.1242/jcs.192021

36. 36.

    Furr SR, Marriott I. Viral CNS infections: role of glial pattern recognition receptors in neuroinflammation. Front. Microbiol. 2012;3:201.

    Not in our library10.3389/fmicb.2012.00201

37. 37.

    Li J, et al. Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons. Glia. 2011;59:58-67.

    Not in our library10.1002/glia.21076

38. 38.

    Sorgeloos F, Kreit M, Hermant P, Lardinois C, Michiels T. Antiviral type I and type III interferon responses in the central nervous system. Viruses. 2013;5:834-857.

    Not in our library10.3390/v5030834

39. 39.

    Jackson CL. Lipid droplet biogenesis. Curr. Opin. Cell Biol. 2019;59:88-96.

    Not in our library10.1016/j.ceb.2019.03.018

40. 40.

    Chapman KD, Aziz M, Dyer JM, Mullen RT. Mechanisms of lipid droplet biogenesis. Biochem. J. 2019;476:1929-1942.

    Not in our library10.1042/bcj20180021

41. 41.

    Tan JSY, Seow CJP, Goh VJ, Silver DL. Recent advances in understanding proteins involved in lipid droplet formation, growth and fusion. J. Genet. Genomics. 2014;41:251-259.

    Not in our library10.1016/j.jgg.2014.03.003

42. 42.

    Olzmann JA, Carvalho P. Dynamics and functions of lipid droplets. Nat. Rev. Mol. Cell Biol. 2019;20:137-155.

    Not in our library10.1038/s41580-018-0085-z

43. 43.

    Lupberger J, et al. Epidermal growth factor receptor signaling impairs the antiviral activity of interferon-alpha. Hepatology. 2013;58:1225-1235.

    Not in our library10.1002/hep.26404

44. 44.

    Ueki, I. F., Min-Oo, G. & Kalinowski, A. Respiratory virus–induced EGFR activation suppresses IRF1-dependent interferon λ and antiviral defense in airway epithelium. J. Exp. Med. 210, 1929–1936 (2013).

    Not in our library10.1084/jem.20121401

45. 45.

    Lulli D, Carbone ML, Pastore S. Epidermal growth factor receptor inhibitors trigger a type I interferon response in human skin. Oncotarget. 2016;7:47777-47793.

    Not in our library10.18632/oncotarget.10013

46. 46.

    Helbig KJ, Beard MR. The role of viperin in the innate antiviral response. J. Mol. Biol. 2014;426:1210-1219.

    Not in our library10.1016/j.jmb.2013.10.019

47. 47.
    Viperin Is Induced following Dengue Virus Type-2 (DENV-2) Infection and Has Anti-viral Actions Requiring the C-terminal End of Viperin · 2013

    No notice
48. 48.

    Helbig KJ, et al. The antiviral protein viperin inhibits hepatitis C virus replication via interaction with nonstructural protein 5A. Hepatology. 2011;54:1506-1517.

    Not in our library10.1002/hep.24542

49. 49.

    Crosse, K. M. et al. Viperin binds STING and enhances the type-I interferon response following dsDNA detection. bioRxiv 493098 (2019) 10.1101/493098.

    Not in our library10.1111/imcb.12420

50. 50.

    Saitoh T, et al. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity. 2011;34:352-363.

    Not in our library10.1016/j.immuni.2011.03.010

51. 51.

    Bosch, M. et al. Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense. Science370, 309 (2020).

    Not in our library10.1126/science.aay8085

52. 52.

    Hubler MJ, Kennedy AJ. Role of lipids in the metabolism and activation of immune cells. J. Nutr. Biochem. 2016;34:1-7.

    Not in our library10.1016/j.jnutbio.2015.11.002

53. 53.

    Antonyak MA, Lukey MJ, Cerione RA. Lipid-filled vesicles modulate macrophages. Science. 2019;363:931-932.

    Not in our library10.1126/science.aaw6765

54. 54.

    Dennis EA, Norris PC. Eicosanoid storm in infection and inflammation. Nat. Rev. Immunol. 2015;15:511-523.

    Not in our library10.1038/nri3859

55. 55.

    Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92-101.

    Not in our library10.1038/nature13479

56. 56.

    Jarc, E. & Petan, T. A twist of FATe: Lipid droplets and inflammatory lipid mediators. Biochimie (2019) 10.1016/j.biochi.2019.11.016.

    Not in our library10.1016/j.biochi.2019.11.016

57. 57.

    Morita M, et al. The lipid mediator protectin D1 inhibits influenza virus replication and improves severe influenza. Cell. 2013;153:112-125.

    Not in our library10.1016/j.cell.2013.02.027

58. 58.

    Beller M, et al. Characterization of the Drosophila lipid droplet subproteome. Mol. Cell. Proteom. 2006;5:1082-1094.

    Not in our library10.1074/mcp.m600011-mcp200

59. 59.

    Hsieh K, et al. Perilipin family members preferentially sequester to either triacylglycerol-specific or cholesteryl-ester-specific intracellular lipid storage droplets. J. Cell Sci. 2012;125:4067-4076.

    Not in our library10.1242/jcs.119768

60. 60.

    Martin S, Driessen K, Nixon SJ, Zerial M, Parton RG. Regulated localization of Rab18 to lipid droplets: effects of lipolytic stimulation and inhibition of lipid droplet catabolism. J. Biol. Chem. 2005;280:42325-42335.

    Not in our library10.1074/jbc.m506651200

61. 61.

    O’Shea RD, et al. Effects of lipopolysaccharide on glial phenotype and activity of glutamate transporters: Evidence for delayed up-regulation and redistribution of GLT-1. Neurochem. Int. 2006;48:604-610.

    Not in our library10.1016/j.neuint.2005.12.028

62. 62.

    Hansen SH, Olsson A, Casanova JE. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J. Biol. Chem. 1995;270:28425-28432.

    Not in our library10.1074/jbc.270.47.28425

63. 63.

    Sheehan KCF, et al. Blocking monoclonal antibodies specific for mouse IFN-α/β receptor subunit 1 (IFNAR-1) from mice immunized by in vivo hydrodynamic transfection. J. Interferon Cytokine Res. 2006;26:804-819.

    Not in our library10.1089/jir.2006.26.804

64. 64.

    Zhou, X. & Moore, B. B. Lung section staining and microscopy. Bio Protoc.7, e2286 (2017).

    Not in our library10.21769/bioprotoc.2286

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.